Globus Medical (GMED) Gross Margin (2011 - 2026)
Globus Medical's (GMED) quarterly Gross Margin came in at 69.42% in Q2 2026, up 280.0% on a YoY basis from 18.27% in Q2 2025, and little changed quarter-over-quarter from 69.2% in Q1 2026.
Analysis
Globus Medical (GMED) Gross Margin (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has reported Gross Margin for 16 consecutive years, with 69.42% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 280.0% year-over-year to 69.42%; the trailing twelve-month figure through Jun 2026 stood at 68.55% (up 579.0% YoY), and the FY2025 full-year result was 67.41%, up 851.0% from the prior year.
- Gross Margin held at 69.42% in Q2 2026 per GMED's latest filing, from 69.2% in the prior quarter.
- Across five years, Gross Margin topped out at 74.4% in Q1 2023 and bottomed at 56.77% in Q3 2024.
- Historically, Gross Margin has averaged 67.25% across 5 years, with a median of 67.87% in 2025.
- The sharpest annual moves came in 2023 and 2025: Gross Margin tumbled 1734 bps in 2023, then soared 1040 bps in 2025.
- Over 5 years, Gross Margin stood at 74.28% in 2022, then dropped by 23 bps to 56.94% in 2023, then gained by 5 bps to 59.92% in 2024, then climbed by 14 bps to 68.41% in 2025, then climbed by 1 bps to 69.42% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 69.42%, 69.2%, and 68.41% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 45.84% |
| 10 | Globus Medical | 9.94 Bn | 9.35 Bn | 548.17 Mn | 69.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.42% |
| Mar 31, 2026 | 69.20% |
| Dec 31, 2025 | 68.41% |
| Sep 30, 2025 | 67.16% |
| Jun 30, 2025 | 66.62% |
| Mar 31, 2025 | 67.33% |
| Dec 31, 2024 | 59.92% |
| Sep 30, 2024 | 56.77% |
| Jun 30, 2024 | 58.70% |
| Mar 31, 2024 | 60.19% |
| Dec 31, 2023 | 56.94% |
| Sep 30, 2023 | 64.71% |
| Jun 30, 2023 | 73.78% |
| Mar 31, 2023 | 74.40% |
| Dec 31, 2022 | 74.28% |
| Sep 30, 2022 | 74.23% |
| Jun 30, 2022 | 74.03% |
| Mar 31, 2022 | 74.34% |
| Dec 31, 2021 | 75.28% |
| Sep 30, 2021 | 74.51% |